Key result
High plasma resolvin D1 linked to ~109% greater odds of culprit plaque rupture in STEMI.
Why the study?
Resolvin D1 inhibits atherosclerosis progression in vivo, but its role in human coronary artery disease remains unclear.
Are higher plasma levels of Resolvin D1 associated with unstable culprit plaque morphologies in patients with STEMI?
Observational (n=240)
Are higher plasma levels of Resolvin D1 associated with unstable culprit plaque morphologies in patients with STEMI?
Odds Ratio: 2.09 (95% CI 1.2–3.66)
p-value: p=0.010
Increased plasma levels of Resolvin D1 are associated with higher instability of coronary atherosclerotic plaques, including rupture and calcification, in patients with STEMI.
Higher RvD1 levels were associated with unstable culprit plaques in STEMI; hypothesis-generating for its role in human atherosclerosis, needing prospective trials.
Background: As a specialized pro-resolving lipid mediator, resolvin D1 (RvD1) inhibits atherosclerosis progression in vivo by reducing regional oxidative stress and chronic inflammation. However, it is unclear how RvD1 is involved in human coronary artery disease. This study aims to investigate the association between plasma levels of RvD1 and culprit-plaque characteristics in patients with ST-segment elevation myocardial infarction (STEMI). Methods: A total of 240 STEMI patients undergoing optical coherence tomography (OCT) examination were analyzed. RvD1 levels were measured in patient plasma samples using an enzyme-linked immunosorbent assay. Logistic regression was performed to assess the association between RvD1 levels and various culprit plaque morphologies, and the receiver operating curve was used to search for an optimal cutoff threshold to predict certain pathological features. Results: The median RvD1 level was 129.7 (56.6-297.8) pg/mL. According to multivariable logistic regression, high RvD1 was associated with plaque rupture (≥111.5 pg/mL, odds ratio [OR]: 2.09, 95% confidence interval [CI]: 1.20-3.66, P = 0.010), healed plaques (≥246.4 pg/mL, OR: 2.17, 95% CI: 1.11-4.24, P = 0.023), and calcification (≥293.38 pg/mL, OR: 2.10, 95% CI: 1.21-3.66, P = 0.008) at culprit lesions. Conclusion: Increased levels of RvD1 were associated with higher instability of coronary atherosclerotic plaques in STEMI patients.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=240). Resolvin D1 (RvD1) vs. Lower RvD1 levels was evaluated on Plaque rupture at culprit lesions (OR 2.09, 95% CI 1.20-3.66, p=0.010). High plasma levels of resolvin D1 were associated with increased odds of plaque rupture (OR 2.09; 95% CI 1.20-3.66; P=0.010) at culprit lesions in STEMI patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: